The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.
Patients With Higher Disease Burden, Lower HRQoL More Likely to Switch to Biologic Therapies
Most Patients With Moderate to Severe Psoriasis Continue Secukinumab Treatment
Psoriasis Risk Linked to Elevated Non-HDL to HDL Cholesterol Ratio, Study Finds
A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.
The Future of Oral Therapy for Psoriasis Management
Zasocitinib’s Potential as an Oral Treatment for Psoriasis
Dr Chesahna Kindred: Diverse Clinical Trials Are a Long-Game to Close the Health Equity Gaps
Dr Chesahna Kindred Addresses Diversity Barriers in Clinical Trials
Dr Chesahna Kindred Discusses the Strengths of Diversity in Psoriasis Clinical Trials
Dr Joseph Zabinski Discusses Challenges in Identifying Patients With GPP
Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP
JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies for Psoriasis
The Importance of Cultural, Social, and Clinical Diversity in Treating Plaque Psoriasis
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
Autoimmune Diseases Prevalent Among Patients With Psoriasis, Study Finds